Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Malin Berglund"'
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background The Swedish Quality Register for Ear Surgery (SwedEar) is a national register monitoring surgical procedures and outcomes of ear surgery to facilitate quality improvement. The value of the register is dependent on the quality of i
Externí odkaz:
https://doaj.org/article/4e98af3c846d4c8d94bf829fa5025b65
Autor:
Tove Selvin, Malin Berglund, Lena Lenhammar, Malin Jarvius, Peter Nygren, Mårten Fryknäs, Rolf Larsson, Claes R Andersson
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background High-throughput screening (HTS) of small molecule drug libraries has greatly facilitated the discovery of new cancer drugs. However, most phenotypic screening platforms used in the field of oncology are based solely on cancer cell
Externí odkaz:
https://doaj.org/article/6a001318eb47461bbdbb33b4e9a1a25b
Autor:
Kristin Blom, Jenny Rubin, Malin Berglund, Malin Jarvius, Lena Lenhammar, Vendela Parrow, Claes Andersson, Angelica Loskog, Mårten Fryknäs, Peter Nygren, Rolf Larsson
Publikováno v:
BMC Research Notes, Vol 12, Iss 1, Pp 1-7 (2019)
Abstract Objective We recently showed that the anti-helminthic compound mebendazole (MBZ) has immunomodulating activity by inducing a M2 to M1 phenotype switch in monocyte/macrophage models. In the present study we investigated the potential role of
Externí odkaz:
https://doaj.org/article/0315674a9bed4c85a44bce844792df11
Autor:
Malin Jarvius, Malin Berglund, Jenny Rubin, Claes Andersson, Vendela Parrow, Angelica Loskog, Kristin Blom, Rolf Larsson, Peter Nygren, Mårten Fryknäs, Lena Lenhammar, Tove Selvin
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports
Scientific Reports
We recently showed that the anti-helminthic compound mebendazole (MBZ) has immunomodulating activity in monocyte/macrophage models and induces ERK signalling. In the present study we investigated whether MBZ induced ERK activation is shared by other
Autor:
Malin Berglund, Eva Westman, Mattias Fransson, Petter Suneson, Per Olof Eriksson, Malou Hultcrantz, Rut Florentzson
Publikováno v:
The Laryngoscope. 129:209-215
Objectives/Hypothesis: Postoperative tinnitus and taste disturbances after myringoplasty are more common than previously reported.Study Design: This study was a retrospective analysis of prospectiv ...
Autor:
Eva Westman, Per Olof Eriksson, Malin Berglund, Erling Englund, Malou Hultcrantz, Rut Florentzson, Mattias Fransson
Publikováno v:
The Laryngoscope. 127:2389-2395
Data from patients registered for myringoplasty during 2002 to 2012 in the Swedish National Quality Registry for Myringoplasty.Both conventional myringoplasty and fat-graft techniques were used aimed at healing the tympanic membrane in noninfected ea
Autor:
Christer Dahlin, Malou Hultcrantz, Mattias Fransson, Sara Olaison, Åsa Bonnard, Per Olof Eriksson, Rut Florentzson, Malin Berglund, Eva Westman
Publikováno v:
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-LaryngologyCervico-Facial SurgeryREFERENCES. 45(3)
To present hearing results after successful primary myringoplasty surgeries registered in the Swedish Quality Registry for Myringoplasty and to evaluate the chance of hearing improvement and the risk of hearing loss.A retrospective nationwide cohort
Autor:
Tomas Luther, Sara Bülow Anderberg, Michael Hultström, Malin Berglund, Miklos Lipcsey, Sten Rubertsson, Rolf Larsson, Robert Frithiof, Anders Larsson
Publikováno v:
Cytokine
Highlights • Fifteen cytokines were increased at ICU admission in Covid-19 patients. • A relatively moderate increase in cytokine concentrations was observed. • IL-1ra, IL-6 and IP-10 correlated with respiratory failure and acute kidney injury.
Autor:
Claes Andersson, Annica J. Rasmusson, Mårten Fryknäs, Malin Berglund, Fredrik Lehmann, Joachim Gullbo, Konstantin Byrgazov, Lena Lenhammar, Ana Slipicevic, Håkan Melhus, Rolf Larsson, Thomas Lind
Publikováno v:
Blood. 136:23-23
Background Melflufen (melphalan flufenamide) is a first-in-class peptide-drug conjugate (PDC) that targets aminopeptidases and rapidly releases alkylating agents into tumor cells. Osteolytic lesions are a hallmark of multiple myeloma and occur in alm
Autor:
Vendela Parrow, Jenny Rubin, Claes Andersson, Malin Jarvius, Wojciech Senkowski, Lena Lenhammar, Mårten Fryknäs, Peter Nygren, Angelica Loskog, Rolf Larsson, Malin Berglund, Kristin Blom
Publikováno v:
Immunopharmacology and immunotoxicology. 39(4)
Mebendazole (MBZ), a drug commonly used for helminitic infections, has recently gained substantial attention as a repositioning candidate for cancer treatment. However, the mechanism of action behind its anticancer activity remains unclear. To addres